PPCB
Propanc Biopharma·NASDAQ
--
--(--)
--
--(--)
4.19 / 10
Netural
Analysis concludes balanced fundamental quality (4.2/10). Favorable components: Interest coverage ratio (EBIT / Interest expense) (%) and Asset-MV, offset by weaknesses in Days sales outstanding. Investment recommendation: defensive.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Days sales outstanding
Value313.91
Score1/3
Weight-2.06%
1M Return-1.57%
Value313.91
Score1/3
Weight-2.06%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.50%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.50%
1M Return-1.11%
Asset-MV
Value-1.05
Score2/3
Weight19.29%
1M Return10.15%
Value-1.05
Score2/3
Weight19.29%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value45.97
Score2/3
Weight1.60%
1M Return1.11%
Value45.97
Score2/3
Weight1.60%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
PB-ROE
Value-0.10
Score2/3
Weight18.65%
1M Return9.14%
Value-0.10
Score2/3
Weight18.65%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value64.40
Score2/3
Weight0.62%
1M Return0.43%
Value64.40
Score2/3
Weight0.62%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Value-0.26
Score3/3
Weight18.76%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value45.97
Score2/3
Weight1.60%
1M Return1.11%
Value45.97
Score2/3
Weight1.60%
1M Return1.11%
Days sales outstanding
Value313.91
Score1/3
Weight-2.06%
1M Return-1.57%
Value313.91
Score1/3
Weight-2.06%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
Value0.46
Score2/3
Weight14.96%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
Value-0.17
Score2/3
Weight14.97%
1M Return8.45%
PB-ROE
Value-0.10
Score2/3
Weight18.65%
1M Return9.14%
Value-0.10
Score2/3
Weight18.65%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.50%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.50%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value64.40
Score2/3
Weight0.62%
1M Return0.43%
Value64.40
Score2/3
Weight0.62%
1M Return0.43%
Asset-MV
Value-1.05
Score2/3
Weight19.29%
1M Return10.15%
Value-1.05
Score2/3
Weight19.29%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Value-0.07
Score2/3
Weight14.71%
1M Return8.41%
Is PPCB undervalued or overvalued?
- PPCB scores 4.19/10 on fundamentals and holds a Fair valuation at present. Backed by its -34.23% ROE, 0.00% net margin, -0.05 P/E ratio, 0.20 P/B ratio, and 101.42% earnings growth, these metrics solidify its Netural investment rating.
